NANOVIRICIDES, INC. Shareholders' Equity
NANOVIRICIDES, INC. (NNVC) had Shareholders' Equity of $9.15 million as of 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-05-15
- 2026-03-31: Stockholders' Equity Attributable to Parent $9.15M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $11.07M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $7.17M.
- 2025-06-30: Stockholders' Equity Attributable to Parent $7.52M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-03-31 | $9.15M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $11.07M 10-Q · filed 2026-05-15 | |
| 2025-09-30 | $7.17M 10-Q · filed 2026-05-15 | |
| 2025-06-30 | $7.52M 10-Q · filed 2026-05-15 | |
| 2025-03-31 | $8.83M 10-Q · filed 2026-05-15 | |
| 2024-12-31 | $10.39M 10-Q · filed 2026-05-15 | |
| 2024-09-30 | $10.11M 10-Q · filed 2026-05-15 | |
| 2024-06-30 | $11.46M 10-Q · filed 2026-05-15 | |
| 2024-03-31 | $10.65M 10-Q · filed 2025-05-15 | |
| 2023-12-31 | $12.45M 10-Q · filed 2025-05-15 | |
| 2023-09-30 | $12.97M 10-Q · filed 2025-05-15 | |
| 2023-06-30 | $14.87M 10-K · filed 2025-09-29 | |
| 2023-03-31 | $18.23M 10-Q · filed 2024-05-15 | |
| 2022-12-31 | $19.87M 10-Q · filed 2024-05-15 | |
| 2022-09-30 | $21.56M 10-Q · filed 2024-05-15 | |
| 2022-06-30 | $23.08M 10-K · filed 2024-09-27 | |
| 2022-03-31 | $24.76M 10-Q · filed 2023-05-15 | |
| 2021-12-31 | $26.47M 10-Q · filed 2023-05-15 | |
| 2021-09-30 | $28.31M 10-Q · filed 2023-05-15 | |
| 2021-06-30 | $29.91M 10-K · filed 2023-10-13 | |
| 2021-03-31 | $31.89M 10-Q · filed 2022-05-16 | |
| 2020-12-31 | $27.75M 10-Q · filed 2022-05-16 | |
| 2020-09-30 | $29.98M 10-Q · filed 2022-05-16 | |
| 2020-06-30 | $21.76M 10-K · filed 2022-10-13 | |
| 2020-03-31 | $14.31M 10-Q · filed 2021-05-14 | |
| 2019-12-31 | $7.72M 10-Q · filed 2021-05-14 | |
| 2019-09-30 | $9.13M 10-Q · filed 2021-05-14 | |
| 2019-06-30 | $10.60M 10-K · filed 2021-10-12 | |
| 2019-03-31 | $12.72M 10-Q · filed 2020-06-22 | |
| 2018-12-31 | $13.84M 10-Q · filed 2020-06-22 | |
| 2018-09-30 | $15.98M 10-Q · filed 2020-06-22 | |
| 2018-06-30 | $17.66M 10-K · filed 2021-10-12 | |
| 2018-03-31 | $19.15M 10-Q · filed 2019-05-15 | |
| 2017-12-31 | $15.92M 10-Q · filed 2019-05-15 | |
| 2017-09-30 | $18.52M 10-Q · filed 2019-05-15 | |
| 2017-06-30 | $20.32M 10-K · filed 2020-10-13 | |
| 2017-03-31 | $22.41M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $19.15M 10-Q · filed 2017-02-14 | |
| 2016-09-30 | $20.23M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $23.05M 10-K · filed 2019-08-23 | |
| 2016-03-31 | $23.98M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $28.38M 10-Q · filed 2016-02-09 | |
| 2015-09-30 | $30.71M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $31.79M 10-K · filed 2018-10-12 | |
| 2015-03-31 | $31.86M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $30.51M 10-Q · filed 2015-02-25 | |
| 2014-09-30 | $32.19M 10-Q/A · filed 2015-02-23 | $36.83M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $23.37M 10-K · filed 2017-09-28 | $28.60M 10-K · filed 2014-09-30 |
| 2014-03-31 | $27.95M 10-Q · filed 2015-05-15 | $32.03M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $7.10M 10-Q · filed 2015-02-25 | $10.21M 10-Q · filed 2014-02-14 |
| 2013-09-30 | $8.31M 10-Q/A · filed 2015-02-23 | $11.75M 10-Q/A · filed 2013-11-18 |
| 2013-06-30 | $8.01M 10-K · filed 2016-09-16 | |
| 2013-03-31 | $10.12M 10-Q/A · filed 2013-05-20 | |
| 2012-12-31 | $14.21M 10-Q/A · filed 2013-02-22 | |
| 2012-09-30 | $12.80M 10-Q/A · filed 2013-02-22 | |
| 2012-06-30 | $13.85M 10-K · filed 2015-09-14 | $13.85M 10-K/A · filed 2012-10-26 |
| 2012-03-31 | $90.00 10-Q/A · filed 2013-02-22 | $13.57M 10-Q · filed 2012-05-21 |
| 2011-12-31 | $12.39M 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $11.39M 10-Q/A · filed 2011-12-12 | |
| 2011-06-30 | $10.17M 10-K · filed 2015-02-23 | |
| 2010-06-30 | $6.52M 10-Q · filed 2014-05-15 | $6.52M 10-Q/A · filed 2011-12-12 |
| 2009-06-30 | $2.49M 10-Q · filed 2014-05-15 | $2.49M 10-Q/A · filed 2011-12-12 |
| 2008-06-30 | $443.74K 10-Q · filed 2014-05-15 | |
| 2007-06-30 | $500.34K 10-Q · filed 2014-05-15 | |
| 2006-06-30 | $1.24M 10-Q · filed 2014-05-15 | |
| 2005-06-30 | -$66.00K 10-Q · filed 2014-05-15 | |
| 2005-05-11 | $0.00 10-K · filed 2014-09-30 | |
| 2005-04-30 | $0.00 10-K/A · filed 2013-10-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |